Global Antacids Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Antacids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global antacids market growth, size, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global antacids market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.
Antacids are over-the-counter (OTC) medications used to neutralize excess stomach acid. They are made from calcium carbonate, aluminum hydroxide, magnesium hydroxide, or a combination. They work by reacting with stomach acid, which effectively reduces its acidity and alleviates discomfort. They are available in various forms, including tablets, liquids, and chewable options. They are commonly used to provide quick relief from conditions like heartburn, indigestion, and sour stomach.
Global Antacids Market Trends and Drivers:
There is an increase in the occurrence of conditions like gastroesophageal reflux disease (GERD), acid reflux, heartburn, indigestion, peptic ulcers, and gastritis. Along with this, the growing elderly population, which is prone to developing these diseases, represents one of the primary factors driving the demand for antacids around the world. This can also be attributed to changing lifestyles, such as irregular dietary habits, sleep patterns, and sedentary lifestyles. Moreover, the rising awareness about digestive health and easier accessibility to OTC medications, which makes it convenient for people to opt for antacids, is favoring the growth of the market. In addition, the growing culture of coffee drinking and social drinking occasions that can result in digestive discomfort is influencing the market positively. Apart from this, the easy availability of antacids via online and offline settings, which include pharmacies and convenience stores, is bolstering the market growth.
Global Antacids Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.
The report segmented the market on the basis of region, drug class, formulation type and distribution channel.
Breakup by Drug Class:
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Pro-Motility Agents
Breakup by Formulation Type:
- Tablet
- Liquid
- Powder
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800